SCHEMBL23809366

SCHEMBL23809366

CC(C)c1cn(COCC[Si](C)(C)C)c2ccc(C(=O)O)cc12

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 1/20 0.45
NPC1 O15118 1/20 0.44
ACE2 Q9BYF1 2/20 0.39
KDM4E B2RXH2 2/20 0.38
HCAR3 P49019 5/20 0.38
MCL1 Q07820 1/20 0.37
PLA2G4A P47712 1/20 0.37
PTPN1 P18031 1/20 0.36
EGFR P00533 1/20 0.35
IGF1R P08069 1/20 0.35
SRC P12931 1/20 0.35
FLT4 P35916 1/20 0.35
KDR P35968 1/20 0.35
FLT3 P36888 1/20 0.35
EPHB4 P54760 1/20 0.35
TEK Q02763 1/20 0.35
KLKB1 P03952 1/20 0.35
HPGD P15428 1/20 0.35
HCAR2 Q8TDS4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26581238 0.85 NPC1 (0.47) SLC22A12NPC1KDM4EHCAR3MCL1
SCHEMBL23809482 0.78 SLC22A12 (0.49) SLC22A12ACE2KDM4EHCAR3HPGD
SCHEMBL30166598 0.77 NPC1 (0.41) SLC22A12NPC1MCL1PLA2G4APTPN1
SCHEMBL23809463 0.76 SLC22A12 (0.52) SLC22A12ACE2KDM4EHCAR3PLA2G4A
SCHEMBL23855061 0.76 NPC1 (0.40) SLC22A12NPC1MCL1PLA2G4AEGFR
SCHEMBL23809523 0.75 SLC22A12 (0.51) SLC22A12ACE2KDM4EHCAR3PLA2G4A
SCHEMBL28878014 0.75 DGAT1 (0.41) SLC22A12NPC1MCL1PTPN1EGFR
SCHEMBL23809221 0.74 HCAR3 (0.40) SLC22A12ACE2KDM4EHCAR3PLA2G4A
SCHEMBL28090346 0.74 HSP90AA1 (0.40) NPC1HPGD
SCHEMBL23809481 0.74 SLC22A12 (0.53) SLC22A12ACE2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 SLC22A12 3136/4885NPC1 2467/4885ACE2 4387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.